Short Interest in Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) Decreases By 18.8%

Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) was the target of a large decrease in short interest in August. As of August 31st, there was short interest totalling 13,000 shares, a decrease of 18.8% from the August 15th total of 16,000 shares. Based on an average daily trading volume, of 5,400 shares, the days-to-cover ratio is presently 2.4 days.

Tevogen Bio Price Performance

NASDAQ:TVGNW opened at $0.02 on Tuesday. Tevogen Bio has a 1 year low of $0.01 and a 1 year high of $0.28. The business has a fifty day moving average of $0.02 and a 200-day moving average of $0.04.

Tevogen Bio Company Profile

Tevogen Bio Holdings Inc operates as a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment and prevention of chronic lingering symptoms of the disease (Long COVID), as well as COVID-19 in B cell immune suppressed acute COVID-19 patients without a B cell cancer indication, elderly and infirm acute COVID-19 patients, and acute COVID-19 in patients on T cell suppressing drugs, including solid organ transplant patients.